• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项回顾性比较研究,评估肢体复发性黑色素瘤采用轻度热灌注与控制性常温灌注的结果。

A retrospective comparative study evaluating the results of mild hyperthermic versus controlled normothermic perfusion for recurrent melanoma of the extremities.

作者信息

Klaase J M, Kroon B B, Eggermont A M, van Geel A N, Schraffordt Koops H, Oldhoff J, Liénard D, Lejeune F J, Berkel R, Franklin H R

机构信息

Department of Surgery, The Netherlands Cancer Institute, Amsterdam.

出版信息

Eur J Cancer. 1995;31A(1):58-63. doi: 10.1016/0959-8049(94)00372-c.

DOI:10.1016/0959-8049(94)00372-c
PMID:7695980
Abstract

The aim of this study was to investigate the role of mild hyperthermia (39-40 degrees C) in isolated cytostatic perfusion for patients with recurrent melanoma of the extremities. A total of 218 patients treated with mild hyperthermic perfusion was compared to 166 patients perfused under controlled normothermic conditions (37-38 degrees C). Only patients whose lesions had been excised before or at the moment of perfusion were eligible for this study. A variety of prognostic factors was controlled for in a Cox proportional hazards analysis. The application of mild hyperthermia did not influence limb recurrence-free interval nor survival (corrected P values 0.46 and 0.18, respectively). In this retrospective comparative study, no benefit for mild hyperthermia in regional isolated perfusion could be identified.

摘要

本研究的目的是探讨轻度热疗(39 - 40摄氏度)在四肢复发性黑色素瘤患者的离体细胞毒性灌注中的作用。将总共218例接受轻度热灌注治疗的患者与166例在可控常温条件下(37 - 38摄氏度)进行灌注的患者进行比较。只有那些在灌注前或灌注时病变已被切除的患者才有资格参与本研究。在Cox比例风险分析中对多种预后因素进行了控制。轻度热疗的应用既不影响肢体无复发生存期,也不影响总生存期(校正P值分别为0.46和0.18)。在这项回顾性比较研究中,未发现轻度热疗在局部离体灌注中有任何益处。

相似文献

1
A retrospective comparative study evaluating the results of mild hyperthermic versus controlled normothermic perfusion for recurrent melanoma of the extremities.一项回顾性比较研究,评估肢体复发性黑色素瘤采用轻度热灌注与控制性常温灌注的结果。
Eur J Cancer. 1995;31A(1):58-63. doi: 10.1016/0959-8049(94)00372-c.
2
Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.用美法仑重复进行肢体隔离灌注治疗肢体复发性黑色素瘤。
J Am Coll Surg. 1996 Jun;182(6):467-72.
3
Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor- alpha versus toxicity after melphalan alone.美法仑与肿瘤坏死因子-α 进行离体肢体灌注后的局部毒性与单独使用美法仑后的毒性比较。
Eur J Surg Oncol. 2001 Jun;27(4):390-5. doi: 10.1053/ejso.2001.1124.
4
Relation between limb toxicity and treatment outcomes after isolated limb perfusion for recurrent melanoma.复发性黑色素瘤孤立肢体灌注术后肢体毒性与治疗结果的关系。
J Am Coll Surg. 1999 May;188(5):522-30. doi: 10.1016/s1072-7515(99)00018-6.
5
Limb recurrence-free interval and survival in patients with recurrent melanoma of the extremities treated with normothermic isolated perfusion.接受常温隔离灌注治疗的肢体复发性黑色素瘤患者的肢体无复发生存期和总生存期
J Am Coll Surg. 1994 Jun;178(6):564-72.
6
Prognostic factors for survival after isolated limb perfusion for malignant melanoma.恶性黑色素瘤孤立肢体灌注术后生存的预后因素。
Eur J Surg Oncol. 2003 Dec;29(10):916-21. doi: 10.1016/j.ejso.2003.09.002.
7
Effective therapy: repeat limb perfusion for recurrent melanoma.有效治疗:复发性黑色素瘤的重复肢体灌注疗法
J Am Coll Surg. 1996 Jun;182(6):547-8.
8
Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan.
Surgery. 1994 Jan;115(1):39-45.
9
Isolated hyperthermic perfusion with mitoxantrone of melphalan in malignant melanoma of the limb.
Am J Surg. 1995 Oct;170(4):345-52. doi: 10.1016/s0002-9610(99)80301-8.
10
Is there an indication for a double perfusion schedule with melphalan for patients with recurrent melanoma of the limbs?对于四肢复发性黑色素瘤患者,美法仑采用双重灌注方案是否有指征?
Melanoma Res. 1994 Mar;4 Suppl 1:13-6.

引用本文的文献

1
Preclinical Validation of a Single-Treatment Infusion Modality That Can Eradicate Extremity Melanomas.一种可根除肢体黑色素瘤的单次治疗输注方式的临床前验证
Cancer Res. 2016 Nov 15;76(22):6620-6630. doi: 10.1158/0008-5472.CAN-15-2764. Epub 2016 Sep 28.
2
Quinacrine for extremity melanoma in a mouse model of isolated limb perfusion (ILP).在孤立肢体灌注(ILP)小鼠模型中使用喹吖因治疗肢体黑色素瘤。
Surg Today. 2015 Mar;45(3):355-62. doi: 10.1007/s00595-014-0952-y. Epub 2014 Jul 8.
3
Initial experiences with isolated limb perfusion for unresectable melanoma of the limb.
肢体局限性灌注治疗不可切除肢体黑色素瘤的初步经验
Ir J Med Sci. 2011 Jun;180(2):517-20. doi: 10.1007/s11845-010-0664-2. Epub 2011 Feb 3.
4
Isolated limb perfusion for extremity soft-tissue sarcomas, in-transit metastases, and other unresectable tumors: credits, debits, and future perspectives.肢体软组织肉瘤、途中转移瘤及其他不可切除肿瘤的隔离肢体灌注:优点、缺点及未来展望
Curr Oncol Rep. 2001 Jul;3(4):359-67. doi: 10.1007/s11912-001-0090-8.
5
Liver and tumour tissue concentrations of TNF-alpha in cancer patients treated with TNF-alpha and melphalan by isolated liver perfusion.通过离体肝脏灌注接受肿瘤坏死因子-α和马法兰治疗的癌症患者肝脏和肿瘤组织中肿瘤坏死因子-α的浓度
Br J Cancer. 1997;75(10):1497-500. doi: 10.1038/bjc.1997.255.